SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense momentum fueled by a fresh defense contract and broader investor interest in memory hardware for AI and data centers. The community is actively debating the potential for a short squeeze, balancing excitement over the company's patented technology and military-grade applications against concerns regarding high valuations and pending legal issues.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative momentum as investors rotate back into Japanese blockchain projects and IoT-focused assets. While community sentiment remains polarized between long-term holders citing ecosystem expansion and skeptics highlighting a lack of official partnership news, traders are closely monitoring technical breakouts and exchange accumulation trends.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the FDA moves to block compounded versions of popular GLP-1 weight-loss drugs, a significant catalyst that strengthens the brand dominance of official products like Wegovy and Ozempic. The community is actively discussing this regulatory shift, with many investors anticipating that the reduced competition will accelerate adoption, boost market share, and act as a tailwind heading into the upcoming earnings report.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is trending as the community closely monitors the potential Senate markup of the Clarity Act, which many believe could provide the regulatory framework necessary to unlock institutional capital. While some investors remain frustrated by recent price consolidation, others are actively tracking increased ETF inflows and new integration partnerships as signals that structural adoption is building for the long term.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are actively debating the future of CRO, with community sentiment split between frustration over persistent token dilution and optimism regarding potential ETF filings and mobile app developments. While some participants are aggressively accumulating, others remain wary, highlighting concerns over management transparency and historical underperformance relative to broader market gains.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following a corporate update regarding financial results and the company's progress toward a pivotal Phase 3 clinical trial for its lead candidate, CAD-1005, aimed at treating heparin-induced thrombocytopenia. While some community members are optimistic about the upcoming trial registration path and orphan drug designations, others are expressing skepticism, focusing on potential share dilution and concerns over aggressive social media promotion.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is attracting significant community attention as it transitions toward a sovereign cloud infrastructure model, with active discussions focusing on its potential to offer an alternative to centralized Big Tech providers like AWS. While investors are debating the long-term impact of deflationary tokenomics and network activity, the community is closely monitoring institutional interest and technical development milestones as catalysts for potential momentum.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending as community members aggressively debate its long-term potential as a high-speed institutional settlement layer, often citing its reported partnership history and infrastructure capabilities. The discussion is heavily polarized between bullish investors highlighting its 11M TPS architecture and potential fintech use cases versus skeptics who dismiss the activity as repetitive spam or an unproven pump-and-dump scheme.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is seeing active community discussion as investors debate its long-term enterprise utility versus ongoing concerns regarding token dilution and price performance. While some participants are accumulating positions in anticipation of future institutional adoption and network upgrades, others are skeptical, focusing on the heavy token supply and historical price volatility.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing heavy selling pressure and frustration from retail investors as the stock continues to underperform relative to broader market rallies. Despite ongoing insider accumulation by CEO Anthony Noto, the community remains divided and skeptical, with many pointing to a lack of near-term catalysts and concerns over share dilution as primary drivers for the stagnant price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GILD Beats Q1 Earnings and Sales Estimates, Lowers '26 EPS View

GILD beats Q1 estimates as HIV and Trodelvy sales rise, but shares slip after the company cuts its 2026 EPS outlook.

Galapagos (NASDAQ:GLPG) Issues Earnings Results

Galapagos (NASDAQ:GLPG - Get Free Report) issued its quarterly earnings data on Wednesday. The biotechnology company reported $0.25 earnings per share for the quarter, beating the consensus estimate of ($1.14) by $1.39. The company had revenue of $7.50 million for the quarter, compared to the...

Galapagos (NASDAQ:GLPG) Sees Large Volume Increase - Here's Why

Galapagos (NASDAQ:GLPG) Sees Strong Trading Volume - Time to Buy...

Galapagos NV (NASDAQ:GLPG) Sees Significant Growth in Short Interest

Galapagos NV (NASDAQ:GLPG - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totaling 1,371,531 shares, a growth of 25.1% from...

Galapagos (GLPG) Expected to Announce Quarterly Earnings on Wednesday

Galapagos (NASDAQ:GLPG) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at...

Galapagos (NASDAQ:GLPG) Shares Pass Below 200-Day Moving Average - Here's What Happened

Galapagos (NASDAQ:GLPG) Stock Passes Below 200 Day Moving Average - Here's Why...

Short Interest in Galapagos NV (NASDAQ:GLPG) Expands By 20.4%

Galapagos NV (NASDAQ:GLPG - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,096,114 shares, an increase of 20.4% from the March 15th total of 910,692 shares. Currently, 1.7% of the company's...

Galapagos (NASDAQ:GLPG) Stock Crosses Below 200 Day Moving Average - Time to Sell?

Galapagos (NASDAQ:GLPG) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell...

Galapagos NV (NASDAQ:GLPG) Given Average Recommendation of "Hold" by Analysts

Galapagos NV (NASDAQ:GLPG - Get Free Report) has been assigned an average recommendation of "Hold" from the seven brokerages that are presently covering the stock, MarketBeat.com reports. One...

Galapagos Partners With Gilead on Gamgertamig, Unlocks $500M Cash and Eyes 2027 Registrational Trials

Galapagos (NASDAQ:GLPG) said it has entered into a binding collaboration agreement with Gilead focused on Gamgertamig, a BCMA x CD3 T-cell engager being developed for autoimmune diseases. Chief Executive Officer Henry Gosebruch said the deal follows "advanced discussions" disclosed the prior week an...

$GLPG Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.22 up 109.44% YoY
• Reported revenue of $6.48M down -91.36% YoY
• Galapagos expects its year-end 2026 cash and financial investments balance to be in the range of 1.98B to 2.05B, a reduction from prior guidance due to Ouro investment and lower interest income.

Stocktwits

Galapagos

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.22 up 109.44% YoY
• Reported revenue of $6.48M down -91.36% YoY
• Galapagos expects its year-end 2026 cash and financial investments balance to be in the range of 1.98B to 2.05B, a reduction from prior guidance due to Ouro investment and lower interest income.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Lakefront Biotherapeutics NV - ADR

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.82	--	--	N/A
Q1 '26	-$0.94	$0.25	126.32%	BEAT
Q4 '25	-$0.13	$5.73	4631.38%	BEAT
Q3 '25	-$0.48	-$3.54	-641.42%	MISSED
Q2 '25	-$0.23	-$0.28	-24.00%	MISSED

GLPG
Galapagos

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest GLPG News

GLPGGalapagos